Malarone treatment failure not associated with previously described mutations in the cytochrome b gene

被引：0
|
作者：
Ole Wichmann
Marion Muehlen
Holger Gruss
Frank P Mockenhaupt
Norbert Suttorp
Tomas Jelinek
机构：
[1] Charité,Institute of Tropical Medicine
[2] Humboldt University,undefined
[3] Virchow Klinikum,undefined
[4] Charité,undefined
[5] Humboldt University,undefined
来源：
Malaria Journal | / 3卷
关键词：
Malaria Parasite; Parasite Density; Artemether; Atovaquone; Proguanil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Malarone® (atovaquone-proguanil) is an effective drug for the treatment and prophylaxis of multidrug-resistant falciparum malaria. However, first cases of resistance have been reported, which are associated with mutations at codon 268 of the parasite's cytochrome b gene. We report the first case of Malarone® treatment failure from Central Africa.
引用
收藏
相关论文
共 50 条
  • [1] Malarone treatment failure not associated with previously described mutations in the cytochrome b gene
    Wichmann, O
    Muehlen, M
    Gruss, H
    Mockenhaupt, FP
    Suttorp, N
    Jelinek, T
    MALARIA JOURNAL, 2004, 3 (1)
  • [2] Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure
    Sharifiyazdi, Hassan
    Namazi, Fatemah
    Oryan, Ahmad
    Shahriari, Reza
    Razavi, Mostafa
    VETERINARY PARASITOLOGY, 2012, 187 (3-4) : 431 - 435
  • [3] Reduced Sensitivity to Azoxystrobin of Monilinia fructicola Isolates From Brazilian Stone Fruits is Not Associated With Previously Described Mutations in the Cytochrome b Gene
    Pereira, Wagner V.
    Primiano, Isabela V.
    Morales, Rafael G. F.
    Peres, Natalia A.
    Amorim, Lilian
    May De Mio, Louise L.
    PLANT DISEASE, 2017, 101 (05) : 766 - 773
  • [4] Detection of atovaquone and Malarone™ resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb)
    Gil, JP
    Nogueira, F
    Strömberg-Nörklit, J
    Lindberg, J
    Carrolo, M
    Casimiro, C
    Lopes, D
    Arez, AP
    Cravo, PV
    Rosário, VE
    MOLECULAR AND CELLULAR PROBES, 2003, 17 (2-3) : 85 - 89
  • [5] Evidence of multiple point mutations in Theileria annulata cytochrome b gene incriminated in buparvaquone treatment failure
    Chatanga, Elisha
    Mosssad, Ehab
    Abubaker, Hazem Abdo
    Alnour, Sondos Amin
    Katakura, Ken
    Nakao, Ryo
    Salim, Bashir
    ACTA TROPICA, 2019, 191 : 128 - 132
  • [6] Previously unclassified mutations at positions experienced treatment failure associated with antiretroviral drug resistance
    Rhee, SY
    Hurley, L
    Zolopa, A
    Fessel, WJ
    Nguyen, DP
    Slome, S
    Smith, S
    Klein, D
    Horberg, M
    Flamm, J
    Follansbee, S
    Shafer, RW
    ANTIVIRAL THERAPY, 2004, 9 (04) : U109 - U110
  • [7] Mutations in Theileria Annulata Cytochrome B Gene Associated with Buparvaquone Resistance in Cattle, Egypt
    Yousef, Sarah G.
    El Balkemy, Farouk A.
    El Damaty, Hend Mohammed
    PAKISTAN VETERINARY JOURNAL, 2020, 40 (02) : 261 - 263
  • [8] Selection of genotypes harbouring mutations in the cytochrome b gene of Theileria annulata is associated with resistance to buparvaquone
    Hacilarlioglu, Selin
    Bilgic, Huseyin Bilgin
    Bakirci, Serkan
    Tait, Andrew
    Weir, William
    Shiels, Brian
    Karagenc, Tulin
    PLOS ONE, 2023, 18 (01):
  • [9] Cytauxzoon felis cytochrome b gene mutation associated with atovaquone and azithromycin treatment
    Hartley, Ashley N.
    Marr, Henry S.
    Birkenheuer, Adam J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2020, 34 (06) : 2432 - 2437
  • [10] Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B
    Hussain, M
    Lok, ASF
    JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) : 183 - 194
12345